The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease

Joaquim Gea, Sergi Pascual, Ady Castro-Acosta, Carmen Hernández-Carcereny, Robert Castelo, Eduardo Márquez-Martín, Concepción Montón, Alexandre Palou, Rosa Faner, Laura I. Furlong, Luis Seijo, Ferran Sanz, Montserrat Torà, Carles Vilaplana, Carme Casadevall, José Luis López-Campos, Eduard Monsó, Germán Peces-Barba, Borja G. Cosío, Alvar AgustíMireia Admetlló, Carlos Alvarez-Martínez, Esther Barreiro, Ferran Casals, Rocío Córdova, Marian García, José G. González-García, Eduardo Márquez, Miren Josune Ormaza, Pau Puigdevall, Luis Seijo, Yolanda Torralba

Research output: Contribution to journalArticleResearch

15 Citations (Scopus)


© 2018 SEPAR Chronic obstructive pulmonary disease (COPD) is an entity with a heterogeneous presentation. For this reason, attempts have been made to characterize different phenotypes and endotypes to enable a more individualized approach. The aim of the Biomarkers in COPD (BIOMEPOC) project is to identify useful biomarkers in blood to improve the characterization of patients. Clinical data and blood samples from a group of patients and healthy controls will be analyzed. The project will consist of an exploration phase and a validation phase. Analytical parameters in blood will be determined using standard techniques and certain ‘omics’ (transcriptomics, proteomics, and metabolomics). The former will be hypothesis-driven, whereas the latter will be exploratory. Finally, a multilevel analysis will be conducted. Currently, 269 patients and 83 controls have been recruited, and sample processing is beginning. Our hope is to use the results to identify new biomarkers that, alone or combined, will allow a better characterization of patients.
Original languageEnglish
Pages (from-to)93-99
JournalArchivos de Bronconeumologia
Publication statusPublished - 1 Feb 2019


  • Biological markers
  • COPD
  • Endotypes
  • Multilevel analysis
  • Personalized medicine


Dive into the research topics of 'The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease'. Together they form a unique fingerprint.

Cite this